Treatment of colitis with resistant starch

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10632142
APP PUB NO 20190262382A1
SERIAL NO

16271089

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Resistant potato starch is demonstrated to have therapeutic effects on ulcerative colitis through attenuation of diarrhea, repair or reduction of intestinal damage, modulation of local gene expression and treatment of intestinal dysbiosis. Administering resistant potato starch in pigs pre-exposed to colitis improved fecal score although use of resistant potato starch as a preventive measure did not prevent diarrhea associated with induction of colitis and in fact impaired the ability of the resistant potato starch to treat ulcerative colitis.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MCPHARMA BIOTECH INCCARBERRY MANITOBA R0K 0H0

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
McLaren, Derek Carberry, CA 8 2
McLaren, Earl Carberry, CA 8 2

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Oct 28, 2027
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 28, 2031
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00